
		<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
		<html xmlns="http://www.w3.org/1999/xhtml">
		<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<title>G.R. No. 88265, December 21, 1989</title>
		<style>
		body{
		margin:10px 30px 10px 30px;
		font-family:times new roman;
		font-size:110%;
		line-height:20px;
		}
		</style>
		</head>

		<body>
				259 Phil. 1005
				<CENTER>				
				<H2>EN BANC</H2>
				<h4>
				G.R. No. 88265, December 21, 1989</h4>
				<H3>SANTIAGO A. DEL ROSARIO, GEORGE G. GACULA, EDGARDO G.
SANTOS, ALBANO S. SIBAL, ALBERTO C. REYES, NONITO P. ARROYO, EMMANUEL F. TERENCIO, DOMINGO S. DE LEON, MODESTO O. LLAMAS,
FARIDA U. ALONTO, ZENAIDA A. FLOIRENDO, ISABEL A. MEJIA, LUZ P. MABANAG, RAMON
H. RABAGO, JR., SAMUEL D. TROCIO AND OSCAR M. BRION, PETITIONERS, VS. HON. ALFREDO R. BENGZON,
IN HIS CAPACITY AS SECRETARY OF THE DEPARTMENT OF HEALTH, RESPONDENT.
<br /><br />D E C I S I O N</H3>
				</CENTER>
				<BR><STRONG>GRIÑO-AQUINO, J.:</STRONG>
				<BR><BR><div align="justify"><p class="BODY">This is a class suit filed by officers of the Philippine Medical
Association, the national <span style="mso-bidi-font-weight:bold">organization </span>of
medical doctors in the Philippines, on behalf of their professional brethren
who are of kindred persuasion, wherein this Court is asked to <span style="mso-bidi-font-weight:bold">declare </span>as unconstitutional, hence,
null and void, some provisions of the Generics Act of 1988 <span style="mso-bidi-font-weight:bold">(Rep. Act No. 6675), and of the implementing
Administrative Order No. 62 issued </span><span style="mso-bidi-font-size:14.0pt">pursuant
thereto, </span><span style="mso-bidi-font-size:16.0pt">specifically:<o:p></o:p></span></p>

<p class="BODY">(<span class="GramE">a</span>) Section 6, Pars. (a) <span class="GramE">and</span> (b) of the Generics Act which provide:<span style="mso-bidi-font-size:11.0pt"><o:p></o:p></span></p>

<blockquote>“(<span class="GramE">a</span>) All government health agencies and
their personnel as well as other government agencies shall use generic
terminology or generic names in all transactions related to purchasing,
prescribing, dispensing and administering of drugs and medicines.</blockquote>

<blockquote>“(b) All medical, dental and veterinary practitioners, including
private practitioners, shall write prescriptions using the generic name.<span style="mso-spacerun:yes">&nbsp; </span>The brand name may be included if so
desired." <span class="GramE">(p. 6, <span class="SpellE">Rollo</span>.)</span></blockquote>

<p class="BODY">(<span class="GramE">b</span>) Section 12, Pars. (<span class="GramE">b</span>), (c) and (d) of the same law which provide:</p>

<blockquote>“b) For the second conviction, the penalty of fine in the amount of
not less than two thousand pesos (P2,000.00) but not exceeding five thousand
pesos (P5,000.00) at the discretion of the court.</blockquote>

<blockquote>“c) For the third conviction, the penalty of fine in the amount of
not less than five thousand pesos (P5,000.00) but not exceeding ten thousand
pesos (P10,000.00) and suspension of his license to practice his profession for
thirty (30) days at the discretion of the court.</blockquote>

<blockquote>“d) For the fourth and subsequent convictions, the penalty of fine
of not less than ten thousand pesos (P10,000.00) and suspension of his license
to practice his profession for one year or longer at the discretion of the
court." <span class="GramE">(pp. 6-7, <span class="SpellE">Rollo</span>.)</span>
<span class="GramE">and</span></blockquote>

<p class="BODY">(c) Sections 4 and 7, Phase 3 of Administrative Order No. 62,
Series of 1989 dated <st1:date year="1989" day="9" month="3">March 9, 1989</st1:date>,
of the respondent Secretary of Health, which read as follows:</p>

<blockquote><span class="GramE">“Section 4.</span><span style="mso-spacerun:yes">&nbsp; </span><i style="mso-bidi-font-style:normal">Violate,
Erroneous and Impossible Prescriptions.<o:p></o:p></i></blockquote>

<blockquote>“4.1.<span style="mso-spacerun:yes">&nbsp;&nbsp; </span><span class="SpellE">Violative</span>
Prescriptions:</blockquote>

<blockquote>“<span class="GramE">4.1.1<span style="mso-spacerun:yes">&nbsp;
</span>Where</span> the generic name is not written;</blockquote>

<blockquote>“<span class="GramE">4.1.2<span style="mso-spacerun:yes">&nbsp;
</span>Where</span> the generic name is not legible and a brand name which is
legible is written;</blockquote>

<blockquote>“<span class="GramE">4.1.3<span style="mso-spacerun:yes">&nbsp;
</span>Where</span> the brand name is indicated and instructions added, such as
the phase ‘No Substitution’ which tend to obstruct, hinder or prevent proper
generic dispensing.</blockquote>

<blockquote>“4.2<span style="mso-spacerun:yes">&nbsp;&nbsp; </span>What to do with <span class="SpellE">Violative</span> Prescriptions.</blockquote>

<blockquote>“<span class="SpellE">Violative</span> Prescriptions shall not be
filled.<span style="mso-spacerun:yes">&nbsp; </span>They shall be kept and reported
by the pharmacist of the drug outlet or any other interested party to the
nearest DOH Officer for appropriate action.<span style="mso-spacerun:yes">&nbsp;
</span>The pharmacist shall advise the <span class="SpellE">prescriber</span> of
the problem and/or instruct the customer to get the proper prescription.</blockquote>

<blockquote>“<span class="GramE">4.3<span style="mso-spacerun:yes">&nbsp;
</span>Erroneous</span> Prescriptions:</blockquote>

<blockquote>“<span class="GramE">4.3.1<span style="mso-spacerun:yes">&nbsp;
</span>When</span> the brand name precedes the generic name.</blockquote>

<blockquote>“<span class="GramE">4.3.2<span style="mso-spacerun:yes">&nbsp;
</span>Where</span> the generic name is the one in parenthesis.</blockquote>

<blockquote>“<span class="GramE">4.3.3<span style="mso-spacerun:yes">&nbsp;
</span>Where</span> the brand name in (sic) not in parenthesis.</blockquote>

<blockquote>“<span class="GramE">4.3.4<span style="mso-spacerun:yes">&nbsp;
</span>Where</span> more than one drug product is prescribed in one
prescription form.</blockquote>

<blockquote>“<span class="GramE">4.4<span style="mso-spacerun:yes">&nbsp; </span>What</span>
to do with erroneous prescriptions.</blockquote>

<blockquote>“Erroneous prescriptions shall be filled.<span style="mso-spacerun:yes">&nbsp; </span>Such prescriptions shall also be kept and
reported by the pharmacist of the drug outlet or any other interested party to
the nearest DOH Office for appropriate action.</blockquote>

<blockquote>x <span class="SpellE">x</span> <span class="SpellE"><span class="GramE">x</span></span><span class="GramE"><span style="mso-spacerun:yes">&nbsp; </span><span class="SpellE">x</span></span>
<span class="SpellE">x</span> <span class="SpellE">x</span><span style="mso-spacerun:yes">&nbsp; </span><span class="SpellE">x</span> <span class="SpellE">x</span> <span class="SpellE">x</span></blockquote>

<blockquote><span class="GramE">“Section 7.</span><i style="mso-bidi-font-style:
normal"><span style="mso-spacerun:yes">&nbsp; </span><span class="GramE">Timetable of
Implementation.</span><o:p></o:p></i></blockquote>

<blockquote>“In order to give all affected parties adequate time for learning
and adjustment, the implementation of these <span style="mso-bidi-font-style:
italic">Rules and Regulations shall in three phases, as follows:<o:p></o:p></span></blockquote>

<blockquote><span style="mso-bidi-font-style:italic">"Phase </span><st1:street><st1:address><span style="mso-bidi-font-style:italic">1 Education Drive</span></st1:address></st1:street><span style="mso-bidi-font-style:italic"> x <span class="SpellE">x</span> <span class="SpellE">x</span><o:p></o:p></span></blockquote>

<blockquote><i>"Phase 2 Monitoring of Compliance x <span class="SpellE">x</span>
<span class="SpellE">x</span><o:p></o:p></i></blockquote>

<blockquote><i><span style="mso-bidi-font-size:12.0pt">"Phase <span class="GramE">3 Implementation</span>.</span></i><i><span style="font-size:12.0pt"><o:p></o:p></span></i></blockquote>

<blockquote><i>"Beginning September 1, 1989 the DOH and the other relevant
agencies of government shall monitor compliance </i><i><span style="mso-bidi-font-size:
13.0pt">with </span>these Rules and Regulations and all violations shall be
subject to the appropriate sanctions and penalties provided for under these
Rules and Regulations and the Generics Act of 1988." <span class="GramE">(pp.
7-9, <span class="SpellE">Rollo</span>.)</span></i></blockquote>

<p class="BODY">On <st1:date year="1989" day="15" month="3">March 15, 1989</st1:date>,
the full text of Republic Act No. 6675 was published in two newspapers of
general circulation in the <st1:country-region><st1:place>Philippines</st1:place></st1:country-region>.<span style="mso-spacerun:yes">&nbsp; </span>The law took effect on <st1:date year="1989" day="30" month="3">March 30, 1989</st1:date>, fifteen (15) days after its
publication, as provided in Section 15 thereof.</p>

<p class="BODY">Section 7, Phase 3 of Administrative Order No. 62 was amended by <span style="mso-bidi-font-weight:bold">Administrative </span>Order No. 76 dated <st1:date year="1989" day="28" month="8">August 28, 1989</st1:date> by postponing to <st1:date year="1990" day="1" month="1">January 1, 1990</st1:date> the <span class="SpellE">effectivity</span> of the sanctions and penalties for violations
of the law, provided in Sections 6 and 12 of the Generics Act and Sections 4
and <span style="mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic">7 </span>of
the Administrative Order.</p>

<p class="BODY">The petitioners allege that "as of this date, there is no
breach or violation yet" of the law (<span style="mso-bidi-font-size:11.0pt">p.
</span>9, <span class="SpellE"><span style="mso-bidi-font-size:14.0pt">Rollo</span></span><span style="mso-bidi-font-size:14.0pt">), </span>which took effect on <st1:date year="1989" day="30" month="3">March 30, 1989</st1:date>.<span style="mso-spacerun:yes">&nbsp; </span>However, as the penal provisions will only
take effect on<span style="mso-bidi-font-size:13.0pt"> </span><st1:date year="1990" day="1" month="1"><span style="mso-bidi-font-size:13.0pt">January
 1, 1990</span></st1:date><span style="mso-bidi-font-size:13.0pt">, it would
have been more accurate to state that "as of this date, no breaches or
violations of the law have been punished yet" (p. 9, <span class="SpellE">Rollo</span>).</span></p>

<p class="BODY">The petition is captioned as an action for declaratory relief,
over which this Court does not <span style="mso-bidi-font-weight:bold">exercise
</span>jurisdiction.<span style="mso-spacerun:yes">&nbsp; </span>Nevertheless, in
view of the public interest involved, we decided to treat it as <span style="mso-bidi-font-style:italic">a </span>petition for prohibition instead.</p>

<p class="BODY">The petitioners' main argument against paragraphs (a) and (b),
Section 6 of the law, is the alleged unequal treatment of government
physicians, dentists, and veterinarians, on one hand, and those in private
practice on the other hand, in the manner of prescribing generic drugs, for,
while the former are allegedly required to use <u><span style="mso-bidi-font-size:
14.0pt">only</span></u><span style="mso-bidi-font-size:14.0pt"> </span>generic
terminology in their prescriptions, the latter may write the brand <span style="mso-bidi-font-size:13.0pt">name of the drug in parenthesis below the
generic name.<span style="mso-spacerun:yes">&nbsp; </span>The favored treatment of
private doctors, dentists and veterinarians under the law is allegedly <span class="GramE">a specie</span> of invalid class legislation.<o:p></o:p></span></p>

<p class="BODY">There is no merit in that argument for it<span style="mso-bidi-font-size:
4.0pt"> </span>proceeds from a misreading and misinterpretation of the letter
and intent of paragraphs (a) and (b), Section 6 <span style="mso-bidi-font-size:
13.0pt">of the Generics Act.<span style="mso-spacerun:yes">&nbsp; </span>Indeed, as
explained by the public respondent:<o:p></o:p></span></p>

<blockquote><i>"x <span class="SpellE"><span style="mso-bidi-font-weight:
bold">x</span></span><span style="mso-bidi-font-weight:bold"> <span class="SpellE">x</span> </span>while paragraph (a) enumerates the government
transactions (‘purchasing, prescribing, dispensing and administering of drugs
and medicines’) where the sole use of</i><i><span style="mso-bidi-font-size:
12.0pt"> </span><span style="mso-bidi-font-weight:bold">generic terminology has
been required, the 'prescription' </span></i><i><span style="mso-bidi-font-size:
12.0pt">of drugs is further governed </span>by </i><i><span style="mso-bidi-font-size:
12.0pt">paragraph (b).<span style="mso-spacerun:yes">&nbsp; </span></span></i><i><u><span style="mso-bidi-font-size:15.0pt">And the use </span></u></i><i><u><span style="mso-bidi-font-size:13.0pt">of the word 'all' in the latter pr</span></u></i><i><u><span style="mso-bidi-font-size:5.0pt;mso-bidi-font-weight:bold">ovision emphasizes
the absence of any distinction between government and </span></u></i><i><u><span style="mso-bidi-font-size:12.0pt;mso-bidi-font-weight:bold">private physicians</span></u></i><i><span style="mso-bidi-font-size:12.0pt;mso-bidi-font-weight:bold">.<span style="mso-spacerun:yes">&nbsp; </span></span><span style="mso-bidi-font-weight:
bold">In other words, </span></i><i><span style="mso-bidi-font-size:13.0pt;
mso-bidi-font-weight:bold">in </span><span style="mso-bidi-font-weight:bold">prescribing
drugs, physicians, whether in government service or </span></i><i><span style="mso-bidi-font-size:7.0pt;mso-bidi-font-weight:bold">in </span><span style="mso-bidi-font-weight:bold">private practice, are both governed by
exactly the same rules, and thus, are both authorized to include the brand name
in their respective prescriptions." <span class="GramE">(p.<span style="mso-bidi-font-size:4.0pt"> </span><span style="mso-bidi-font-size:12.0pt;
mso-bidi-font-weight:normal">44, <span class="SpellE">Rollo</span>.)</span></span></span></i><i><span style="mso-bidi-font-size:12.0pt"><o:p></o:p></span></i></blockquote>

<p class="BODY">Furthermore, it may be observed that while paragraph (a) refers
to "all government health agencies, and their personnel as well as other
government agencies" (not necessarily physicians, dentists and <span style="mso-bidi-font-size:4.0pt;mso-bidi-font-weight:bold">veterinarians), </span>paragraph
(b) refers to <span style="mso-bidi-font-size:16.0pt">"<u>all </u></span><u><span style="mso-bidi-font-size:15.0pt">medical, dental and veterinary practitioners,
including private practitioners</span></u><span style="mso-bidi-font-size:15.0pt">."<u><o:p></o:p></u></span></p>

<p class="BODY">Petitioners concede that the requirement for doctors, dentists,
and veterina<span style="mso-bidi-font-size:16.0pt">r</span>ians to use the
generic terminology in writing their prescriptions, followed by the brand name
in parenthesis, is "well and good" (p. 12, <span class="SpellE">Rollo</span>).<span style="mso-spacerun:yes">&nbsp; </span>However, they complain that under paragraph
(d) of the law which reads:</p>

<blockquote><i style="mso-bidi-font-style:normal">"(d) Drug outlets,
including drugstores, hospital and non-hospital pharmacies and non-traditional
outlets such as supermarkets and stores, shall inform any buyer about any and
all other drug products having the same</i><i style="mso-bidi-font-style:normal"><span style="mso-bidi-font-size:12.0pt"> generic name, </span><span style="mso-bidi-font-weight:
bold">together with their corresponding prices so </span></i><i style="mso-bidi-font-style:normal"><span style="mso-bidi-font-size:4.0pt;
mso-bidi-font-weight:bold">that </span><span style="mso-bidi-font-weight:bold">the
buyer may adequately exercise his option.<span style="mso-spacerun:yes">&nbsp;
</span>Within one (1) year after approval of this Act, the drug outlets
referred to herein, shall post </span></i><i style="mso-bidi-font-style:normal"><span style="mso-bidi-font-size:12.0pt">in conspicuous places in their </span><span style="mso-bidi-font-weight:bold">establishments, a </span></i><i style="mso-bidi-font-style:normal"><span style="mso-bidi-font-size:12.0pt">list
of drug products with the same generic name and their corresponding
prices." <span class="GramE">(Annex A, p. 23, <span class="SpellE">Rollo</span>.)</span><o:p></o:p></span></i></blockquote>

<p class="BODY" style="text-indent:0in"><span class="GramE">the</span> salesgirl at
the drugstore counter is authorized to "substitute the prescribed medicine
with another medicine belonging to the same generic group." Since doctors
are <span style="mso-bidi-font-style:italic">not </span>allowed to instruct the
druggist not to substitute the prescription, or to "Dispense only as
Prescribed" (per Sec. 4, Adm. Order No. 62), the petitioners argue that
"the act of prescribing the correct medicine for the patient becomes the
act of the salesgirl at the drugstore counter, no longer the act of the
physician, dentist, or veterinarian" (p. 12, <span class="SpellE">Rollo</span>).</p>

<p class="BODY">Here again, the petitioners have distorted the clear provisions
of the law and the implementing administrative order.<span style="mso-spacerun:yes">&nbsp; </span>For it is plain to see that neither paragraph
(d) of Section 6 of the Generics Act, nor Section 4 of Administrative Order No.
62, gives the salesgirl and/or druggist the discretion <u>to substitute </u><span style="mso-bidi-font-size:14.0pt">the doctor's prescription.</span><span style="mso-bidi-font-style:italic"><o:p></o:p></span></p>

<p class="BODY">On the contrary, Section 4, par. 4.1, of Administrative Order No.
62 directs the pharmacist <u>not to fill</u> "<span class="SpellE">violative</span>
prescriptions" (where the generic name is not written, or illegibly
written, and the prescription of a brand name is accompanied by the doctor's
instruction not to substitute it), as well as <span style="mso-bidi-font-size:
11.0pt;mso-bidi-font-weight:bold">"<u>impossible prescriptions</u>" </span><span style="mso-bidi-font-size:14.0pt">(par. 4.5).<span style="mso-spacerun:yes">&nbsp;
</span>Even a doctor's "erroneous" prescriptions "shall be
filled," not substituted (par. 4.3, Adm. Order No. 62).<span style="mso-spacerun:yes">&nbsp; </span>And, Sections 3 and 5 of Adm. Order No. 63
enjoin the drug outlets "not (to) favor or suggest" or
"impose" a </span>particular brand or product on the customer.<span style="mso-spacerun:yes">&nbsp; </span>The administrative order provides:</p>

<blockquote><i>"In order </i><i><span style="mso-bidi-font-size:14.0pt">to
</span>ensure the informed choice and use of drugs by the </i><i><span style="mso-bidi-font-size:12.0pt;mso-bidi-font-weight:bold">patient/buyer, <u>the
drug outlet </u></span></i><i><u><span style="mso-bidi-font-size:13.0pt;
mso-bidi-font-weight:bold">is </span></u></i><i><u><span style="mso-bidi-font-size:
12.0pt;mso-bidi-font-weight:bold">required to</span></u></i><i><span style="mso-bidi-font-size:12.0pt;mso-bidi-font-weight:bold">:<o:p></o:p></span></i></blockquote>

<blockquote><i>"3.1.1 Inform the
patient/buyer of all available drug products generically equivalent to the one </i><i><span style="mso-bidi-font-size:12.0pt">prescribed with their corresponding
prices.<span style="mso-spacerun:yes">&nbsp; </span>In so doing, <u>the drug outlet
shall not favor or suggest any particular </u></span><u>product so that the
patient/buyer <span style="mso-bidi-font-weight:bold">may fully and adequately
exercise </span></u></i><i><u><span style="mso-bidi-font-size:16.0pt">his </span></u></i><i><u><span style="mso-bidi-font-size:12.0pt">option to choose</span></u></i><i><span style="mso-bidi-font-size:12.0pt"> </span></i><i><span style="mso-bidi-font-size:
13.0pt">(Sec. </span></i><i><span style="mso-bidi-font-size:12.0pt">3, Adm.
Order No. 63 s. 1989).<o:p></o:p></span></i></blockquote>

<blockquote><i>x <span class="SpellE">x</span>
<span class="SpellE">x</span><span style="mso-tab-count:3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>x
<span class="SpellE">x</span> <span class="SpellE">x</span><span style="mso-tab-count:
3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>x <span class="SpellE">x</span> <span class="SpellE">x</span><o:p></o:p></i></blockquote>

<blockquote><i><span style="mso-bidi-font-size:14.0pt;mso-bidi-font-weight:
bold">"<u>The following </u></span><u>acts or omissions </u></i><i><u><span style="mso-bidi-font-size:13.0pt">are considered violations of these </span>rules
and regulations</u>:</i></blockquote>

<blockquote><span class="GramE"><i>"5. 1 <u>Imposin</u></i><i><u><span style="mso-bidi-font-size:15.0pt">g a</span></u></i><i><u><span style="mso-bidi-font-size:12.0pt"> <span class="SpellE">particualar</span> brand
or product on the buyer</span></u></i><i><span style="mso-bidi-font-size:12.0pt">.</span></i></span><i><span style="mso-bidi-font-size:12.0pt"><span style="mso-spacerun:yes">&nbsp; </span><span class="GramE">x <span class="SpellE">x</span> <span class="SpellE">x</span>."</span>
</span><span class="GramE">(pp. <span style="mso-bidi-font-size:12.0pt">46-47, <span class="SpellE">Rollo</span>.)</span></span></i><i><span style="mso-bidi-font-size:
12.0pt"><o:p></o:p></span></i></blockquote>

<p class="BODY">The salesgirl at the drugstore counter merely <u><span style="mso-bidi-font-weight:bold">informs</span></u><span style="mso-bidi-font-weight:
bold"> </span>the customer, but does not determine (for she is incompetent to
do so), all the other drug products or brands that have the same generic name,
and their corresponding prices.<span style="mso-spacerun:yes">&nbsp; </span>That
information she may obtain from the list of drug products determined by the
Bureau of Food and Drugs to have the same generic name, or which are the
chemical, biological, and therapeutic equivalent of the generic drug.<span style="mso-spacerun:yes">&nbsp; </span>All drugstores or drug outlets are required
by the law to post such list in a conspicuous place in their premises for the
information of the customers, for the choice of whether to buy the expensive brand-name
drug, or the less expensive generic, should be exercised by the customer alone.</p>

<p class="BODY">The purpose of the Generics Act is to carry out the policy of the
State:<span style="mso-bidi-font-size:11.0pt"><o:p></o:p></span></p>

<blockquote><i><span style="mso-bidi-font-size:13.0pt">"To </span>promote,
encourage and require the use of generic terminology <span style="mso-bidi-font-weight:
bold">in </span>the importation, manufacture, distribution, marketing,
advertising and promotion, prescription and dispensing of drugs;<o:p></o:p></i></blockquote>

<blockquote><i>"To ensure the adequate supply of drugs with generic <span style="mso-bidi-font-weight:bold">names at </span>the lowest possible cost and
endeavor to make them <span style="mso-bidi-font-weight:bold">available </span>for
free to indigent patients;<o:p></o:p></i></blockquote>

<blockquote><i>"To encourage the <span style="mso-bidi-font-weight:bold">extensive
use </span>of drugs with generic names through a rational system of procurement
and distribution;<o:p></o:p></i></blockquote>

<blockquote><i>"To emphasize the scientific basis for the use of drugs, in
order that health professionals may become more aware and cognizant of their
therapeutic effectiveness; and<o:p></o:p></i></blockquote>

<blockquote><span class="GramE"><i>"To promote drug safety </i><i><span style="mso-bidi-font-size:13.0pt">by </span></i><i><span style="mso-bidi-font-size:
12.0pt">minimizing duplication in medications and/or use of drugs with
potentially </span><span style="mso-bidi-font-weight:bold">adverse </span></i><i><span style="mso-bidi-font-size:12.0pt">drug interactions."</span></i></span><i><span style="mso-bidi-font-size:12.0pt"> <span class="GramE">(pp. <span style="mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold">38­-39, <span class="SpellE">Rollo</span>.)</span></span></span></i><span style="mso-bidi-font-weight:
bold"><o:p></o:p></span></blockquote>

<p class="BODY" style="text-indent:0in"><span class="GramE">or</span>, as stated by
the public respondent, "to promote and require the use of generic drug
products that are therapeutically equivalent to their brand-name <span style="mso-bidi-font-size:13.0pt">counterparts" (p. 39, <span class="SpellE">Rollo</span>) for "<u>the therapeutic effect </u></span><u><span style="mso-bidi-font-size:14.0pt">of </span></u><u><span style="mso-bidi-font-size:
13.0pt">a drug does not depend on its 'brand' but </span></u><u><span style="mso-bidi-font-size:11.0pt">on </span></u><u><span style="mso-bidi-font-size:
13.0pt">the 'active ingredients' which it contains." The medicine that
cures is the "active ingredient" of the drug, and not the brand name
by which it has been baptized by the manufacturer</span></u><span style="mso-bidi-font-size:13.0pt">.<u><o:p></o:p></u></span></p>

<p class="BODY">The public respondent points out that the institution of generics
in the <st1:country-region><st1:place>Philippines</st1:place></st1:country-region>
will compel physicians to prescribe drugs based on their therapeutic or
"active ingredient," instead of their <span style="mso-bidi-font-size:
13.0pt">well-known brand names.<span style="mso-spacerun:yes">&nbsp; </span>Multiple
medications which may produce potentially adverse, even lethal, chemical </span>reactions
in the patient will thereby be avoided.<span style="mso-spacerun:yes">&nbsp;
</span>Patients with limited means will be able to buy generic drugs that cost
less but possess the same active ingredients, dosage form, and strength as
brand names, many of which <span style="mso-bidi-font-size:11.0pt;mso-bidi-font-weight:
bold">are </span>priced beyond the reach of the common <span class="SpellE"><u><span style="mso-bidi-font-size:11.0pt">tao</span></u></span><span style="mso-bidi-font-size:
11.0pt"> </span>because the high costs of advertising, packaging, royalties,
and other inputs of production determine their pricing for the market.</p>

<p class="BODY">The Court has been unable to find any constitutional infirmity <span style="mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold">in </span>the
Generics Act.<span style="mso-spacerun:yes">&nbsp; </span>It, on the contrary,
implements the constitutional mandate for the State "to protect and
promote the right to health of the people" and "to make essential
goods, health and other social services available to all the people <u>at </u><u><span style="mso-bidi-font-size:11.0pt">affordable cost</span></u><span style="mso-bidi-font-size:11.0pt">" </span>(Section 15, Art. <span class="GramE">II and Section 11, Art.</span> XIII, 1987 Constitution).</p>

<p class="BODY">The prohibition against the use by doctors of "no
substitution" and/or words of similar import in their prescription, is a
valid regulation to prevent the circumvention of the law.<span style="mso-spacerun:yes">&nbsp; </span>It secures to the <span style="mso-bidi-font-size:
15.0pt">patient </span>the right to choose between the brand name and its
generic equivalent since his doctor is allowed to write both the generic and
the brand name in his prescription form.<span style="mso-spacerun:yes">&nbsp;
</span>If a doctor is allowed to prescribe a brand-name drug with "no
substitution," the patient's option to buy a lower-priced, but equally
effective, generic equivalent would thereby be curtailed.<span style="mso-spacerun:yes">&nbsp; </span>The law <span style="mso-bidi-font-size:11.0pt;
mso-bidi-font-weight:bold">aims </span>to benefit the impoverished (and often
sickly) majority of the population in a still developing country like ours, not
the affluent and generally healthy minority.</p>

<p class="BODY">There is no merit in the petitioners' theory that the Generics
Act impairs the obligation of contract between a physician and his patient, for
no contract ever results from a consultation between patient and
physician.<span style="mso-spacerun:yes">&nbsp; </span><span style="mso-bidi-font-weight:
bold">A </span>doctor may take in or refuse a patient, just as the patient may
take or refuse the doctor's advice or prescription.<span style="mso-spacerun:yes">&nbsp; </span>As aptly <span style="mso-bidi-font-weight:
bold">observed by the public respondent, no doctor has ever filed an action for
breach </span><span style="mso-bidi-font-size:13.0pt">of contract against </span><span style="mso-bidi-font-weight:bold">a </span><span style="mso-bidi-font-size:
13.0pt">patient who refused to take prescribed medication, undergo surgery, or
follow </span><span style="mso-bidi-font-weight:bold">a </span><span style="mso-bidi-font-size:13.0pt">recommended course treatment by his doctor
(p. 53, <span class="SpellE">Rollo</span>).<span style="mso-spacerun:yes">&nbsp;
</span>In any event, no private contract between doctor and patient may be
allowed to override the power of the State to enact laws that are reasonably
necessary to secure the health, safety, good order, comfort, or general welfare
of the community.<span style="mso-spacerun:yes">&nbsp; </span>This power can neither
be abdicated nor bargained away.<span style="mso-spacerun:yes">&nbsp; </span>All
contractual and property </span><span style="mso-bidi-font-weight:bold">rights
are </span><span style="mso-bidi-font-size:13.0pt">held subject to its </span><span style="mso-bidi-font-weight:bold">fair exercise (Anglo-<span class="SpellE">Fil</span>
Trading Corporation vs. <span class="SpellE">Lazaro</span>, 124 SCRA 495).<o:p></o:p></span></p>

<p class="BODY"><span style="mso-bidi-font-weight:bold">Petitioners have also
assailed Section </span>12, paragraphs b, c and d, of the Generics Act
prescribing <span style="mso-bidi-font-weight:bold">graduated penalties
(ranging from a reprimand to a fine </span>of not less that P10,000 and the
suspension of the physician's license to <span style="mso-bidi-font-weight:
bold">practice his profession for one [1] year or longer, at the discretion of
the court) for violations of its provisions.<span style="mso-spacerun:yes">&nbsp;
</span>Petitioners' allegation that these penalties violate the constitutional
guarantee against excessive fines and cruel and degrading <span class="GramE">punishment,</span>
has no merit.<span style="mso-spacerun:yes">&nbsp; </span>Penal sanctions are
indispensable if the law is </span>to be obeyed.<span style="mso-spacerun:yes">&nbsp; </span>They are the "teeth" of the
law.<span style="mso-spacerun:yes">&nbsp; </span>Without them, the law would be
toothless, not worth the paper it is printed on, for physicians, dentists and
veterinarians may freely ignore its prescriptions and prohibitions.<span style="mso-spacerun:yes">&nbsp; </span>The penalty of suspension or cancellation of
the physician's license is <span class="GramE">neither cruel, inhuman, or</span>
degrading.<span style="mso-spacerun:yes">&nbsp; </span>It is no different from the
penalty of suspension or disbarment that this Court inflicts on lawyers and
judges who misbehave or violate the laws and the Codes of Professional and
Judicial Conduct.</p>

<p class="BODY">We hold that the Generics Act and the implementing administrative
orders of the Secretary of Health are constitutional.<span style="mso-spacerun:yes">&nbsp; </span>In light of its beneficial provisions, we
cannot heed the petitioners' plea to kill it <span class="SpellE">aborning</span>,
i.e., before it has had a chance to prove its value to our people as envisioned
by its makers.</p>

<p class="BODY"><b>WHEREFORE</b>, the petition is dismissed for lack of
merit.<span style="mso-spacerun:yes">&nbsp; </span><span class="GramE">Costs against
the petitioners.</span></p>

<p class="SOORDERED"><span class="GramE">SO ORDERED.</span></p>

<span style="font-style:italic"><span class="SpellE">Fernan</span>, C.J., <span class="SpellE">Narvasa</span>,
Cruz, <span class="SpellE">Paras</span>, Feliciano, <span class="SpellE">Gancayco</span>,
Padilla, <span class="SpellE">Bidin</span>, <span class="SpellE">Sarmiento</span>,
Cortes, <span class="SpellE">Medialdea</span>, <span style="font-style:normal">and</span>
<span class="SpellE">Regalado</span>, <span class="GramE">JJ.,</span><span style="font-style:normal"> concur.<o:p></o:p></span></span><br>

<span style="font-style:italic"><span class="SpellE">Melencio-Hererra</span>, J.,<span style="font-style:normal"> in the result.<o:p></o:p></span></span><br>

<span style="font-style:italic">Gutierrez, Jr., J.,<span style="font-style:normal"> concurs in
the result only because of the failure to overcome the presumption of the constitutionality
and not because the respondent’s arguments are valid.<o:p></o:p></span></span><br>

</div>
				<BR><BR>
				
				<HR SIZE='1px' style='margin-top:20px;'>
				<br />
				<center>
				<small style='font-size:10px;line-height:11px;color:#666666;'>
				<!--
				Date created: October 27, 2014
				-->
				</small>
				</center>	
		</body>
		</html>
		